PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE CANCER, AND METHOD FOR TREATING PROSTATE CANCER

摘要

Disclosed is a pharmaceutical composition for treating prostate cancer, which can exhibit the therapeutic effect locally and therefore can produce no systemic adverse side effect, and can largely reduce physical or mental pain or distress in a patient.  Also disclosed is a method for treating prostate cancer by using the composition.  The pharmaceutical composition for treating prostate cancer comprises a gene which encodes a fusion protein composed of a domain which is derived from endothelial cell locus 1 protein and on which an extracellular matrix can be deposited and a testosterone-degrading enzyme.